Correlation Between Amkor Technology and Rapport Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amkor Technology and Rapport Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amkor Technology and Rapport Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amkor Technology and Rapport Therapeutics, Common, you can compare the effects of market volatilities on Amkor Technology and Rapport Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amkor Technology with a short position of Rapport Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amkor Technology and Rapport Therapeutics,.

Diversification Opportunities for Amkor Technology and Rapport Therapeutics,

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Amkor and Rapport is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Amkor Technology and Rapport Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics, and Amkor Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amkor Technology are associated (or correlated) with Rapport Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics, has no effect on the direction of Amkor Technology i.e., Amkor Technology and Rapport Therapeutics, go up and down completely randomly.

Pair Corralation between Amkor Technology and Rapport Therapeutics,

Given the investment horizon of 90 days Amkor Technology is expected to generate 0.32 times more return on investment than Rapport Therapeutics,. However, Amkor Technology is 3.09 times less risky than Rapport Therapeutics,. It trades about 0.02 of its potential returns per unit of risk. Rapport Therapeutics, Common is currently generating about -0.22 per unit of risk. If you would invest  2,661  in Amkor Technology on September 12, 2024 and sell it today you would earn a total of  7.00  from holding Amkor Technology or generate 0.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Amkor Technology  vs.  Rapport Therapeutics, Common

 Performance 
       Timeline  
Amkor Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amkor Technology has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest inconsistent performance, the Stock's forward-looking signals remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Rapport Therapeutics, 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Rapport Therapeutics, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively abnormal basic indicators, Rapport Therapeutics, reported solid returns over the last few months and may actually be approaching a breakup point.

Amkor Technology and Rapport Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amkor Technology and Rapport Therapeutics,

The main advantage of trading using opposite Amkor Technology and Rapport Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amkor Technology position performs unexpectedly, Rapport Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will offset losses from the drop in Rapport Therapeutics,'s long position.
The idea behind Amkor Technology and Rapport Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets